Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS). (Q33406356)

26 July 2017

title

Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS). (English)

1 reference

26 July 2017

9

Ulrich Budde

0 references

author name string

Friedrich Modde

1

1 reference

26 July 2017

Putri Andina Agustian

2

1 reference

26 July 2017

Juliane Wittig

3

1 reference

26 July 2017

Maximilian Ernst Dämmrich

4

1 reference

26 July 2017

Vinzent Forstmeier

5

1 reference

26 July 2017

Udo Vester

6

1 reference

26 July 2017

Thurid Ahlenstiel

7

1 reference

26 July 2017

Kerstin Froede

8

1 reference

26 July 2017

Anne-Margret Wingen

10

1 reference

26 July 2017

Anke Schwarz

11

1 reference

26 July 2017

Svjetlana Lovric

12

1 reference

26 July 2017

Jan Thomas Kielstein

13

1 reference

26 July 2017

Carsten Bergmann

14

1 reference

26 July 2017

Nadine Bachmann

15

1 reference

26 July 2017

Mato Nagel

16

1 reference

26 July 2017

Hans Heinrich Kreipe

17

1 reference

26 July 2017

Verena Bröcker

18

1 reference

26 July 2017

Clemens Luitpold Bockmeyer

19

1 reference

26 July 2017

Jan Ulrich Becker

20

1 reference

26 July 2017

publication date

9 March 2013

1 reference

26 July 2017

1 reference

26 July 2017

volume

462

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

455-464

1 reference

Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome?

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Thrombomodulin mutations in atypical hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Activation of the classical pathway of complement by Hageman factor fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Plasmatic parameters of coagulation activation in thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Plasminogen activator inhibitor type-1 and interleukin-6 in haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

New equations to estimate GFR in children with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

New insights into the molecular mechanisms of the fibrinolytic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Chronic exposure to laminar shear stress induces Kruppel-like factor 2 in glomerular endothelial cells and modulates interactions with co-cultured podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Thrombomodulin and its role in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Comparison of the inhibition of thrombin by three plasma protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Inhibition of bone morphogenetic protein 1 by native and altered forms of alpha2-macroglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

Generation of C5a in the absence of C3: a new complement activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1386-4

C5a induces tissue factor activity on endothelial cells

21 January 2018

1 reference

12 December 2020

Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia

1 reference

12 December 2020

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome

1 reference

12 December 2020

The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.

1 reference

12 December 2020

Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome

1 reference

12 December 2020

Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study

1 reference

12 December 2020

Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase.

1 reference

12 December 2020

Autoantibodies in haemolytic uraemic syndrome (HUS).

1 reference

12 December 2020

Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies

1 reference

12 December 2020

Effect of antisense KLF4 gene on the expression of vWF and PAI-1 in endothelium cells

1 reference

12 December 2020

Mitomycin-induced hemolytic-uremic syndrome.

1 reference

12 December 2020

Alpha-2-macroglobulin inhibits the anticoagulant action of activated protein C in cord and adult plasma

1 reference

12 December 2020

De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine

1 reference

12 December 2020

Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo

1 reference

12 December 2020

Role of the VEGF--a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier

1 reference

12 December 2020

Transforming growth factor-β-induced collagen synthesis by human liver myofibroblasts is inhibited by α2-macroglobulin

1 reference

12 December 2020

Hypocomplementaemia due to a genetic deficiency of beta 1H globulin

1 reference

12 December 2020

Inhibition of human blood coagulation factor Xa by alpha 2-macroglobulin

1 reference

12 December 2020

Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat).

1 reference

12 December 2020

10.1007/S00428-013-1386-4

Identifiers

DOI

1 reference

26 July 2017

1 reference